Related stories
Vijay Pande — who left a16z's roughly $4 billion biotech practice last year to start the much smaller, AI-native VZVC — talks about why biology is finally shifting from a "discovery" science to an "engineering" one, why clinical trials are still brutally expensive, and why he thinks open, shared datasets (not walled-off ones) are what will actually let AI transform medicine.
Alt-right troll Milo Yiannopoulos was arrested by ICE on Thursday, and today the Department of Homeland Security confirmed to Reuters and the Washington Post that he had been deported to the UK. Yiannopoulos came to the US legally in 2019, but overstayed his visa. After he failed to appear in court for an immigration hearing, […]
Quarterly revenue also more than doubled, to $96.22 billion, the company said, topping expectations on Wall Street.
The prolific voice actor also appeared in Knight Rider, Gremlins, King Kong, Crystal Crisis, and plenty more.